Zealand Pharma A/S
ZLDPF
$61.52
-$6.48-9.53%
Weiss Ratings | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.58 | |||
Price History | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -24.88% | |||
30-Day Total Return | -43.19% | |||
60-Day Total Return | -37.11% | |||
90-Day Total Return | -38.06% | |||
Year to Date Total Return | -38.29% | |||
1-Year Total Return | -32.98% | |||
2-Year Total Return | 76.38% | |||
3-Year Total Return | 297.03% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -52.03% | |||
52-Week Low % Change | 2.41% | |||
Price | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $141.74 | |||
52-Week Low Price | $66.40 | |||
52-Week Low Price (Date) | Apr 02, 2025 | |||
52-Week High Price (Date) | Aug 16, 2024 | |||
Valuation | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 4.76B | |||
Enterprise Value | 3.50B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -2.36 | |||
Earnings Per Share Growth | 29.50% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 530.84 | |||
Price/Book (Q) | 4.02 | |||
Enterprise Value/Revenue (TTM) | 386.31 | |||
Price | $61.52 | |||
Enterprise Value/EBITDA (TTM) | -16.08 | |||
Enterprise Value/EBIT | -19.04 | |||
Market Cap Category | Mid Cap | |||
Dividends and Shares | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 70.74M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 45 88 77 36 00 | |||
Address | -- | |||
Website | www.zealandpharma.com | |||
Country | Denmark | |||
Year Founded | 1997 | |||
Profitability | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -2,029.18% | |||
Profit Margin | -1,724.81% | |||
Management Effectiveness | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -14.26% | |||
Return on Equity | -- | |||
Income Statement | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 9.07M | |||
Total Revenue (TTM) | 9.07M | |||
Revenue Per Share | $0.13 | |||
Gross Profit (TTM) | 7.95M | |||
EBITDA (TTM) | -217.76M | |||
EBIT (TTM) | -183.98M | |||
Net Income (TTM) | -156.38M | |||
Net Income Avl. to Common (TTM) | -156.38M | |||
Total Revenue Growth (Q YOY) | -61.42% | |||
Earnings Growth (Q YOY) | -8.82% | |||
EPS Diluted (TTM) | -2.36 | |||
EPS Diluted Growth (Q YOY) | 10.19% | |||
Balance Sheet | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.14B | |||
Cash Per Share (Q) | $16.14 | |||
Total Current Assets (Q) | 1.18B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.20B | |||
Current Ratio (Q) | 21.136 | |||
Book Value Per Share (Q) | $16.93 | |||
Total Assets (Q) | 1.32B | |||
Total Current Liabilities (Q) | 56.01M | |||
Total Debt (Q) | 54.38M | |||
Total Liabilities (Q) | 123.39M | |||
Total Common Equity (Q) | 1.20B | |||
Cash Flow | ZLDPF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -1.08B | |||
Cash from Financing (TTM) | 1.20B | |||
Net Change in Cash (TTM) | -15.57M | |||
Levered Free Cash Flow (TTM) | -113.22M | |||
Cash from Operations (TTM) | -135.26M | |||